Table 2.
Intake by quartile | p trend | ||||
---|---|---|---|---|---|
Lowest | Second | Third | Highest | ||
Arsenic | |||||
Men | |||||
Median intake (μg/day) | 88.8 | 127.8 | 166.1 | 247.5 | |
Number of cases | 1,002 | 1,038 | 1,116 | 1,167 | |
Person-years of follow-up | 112,502 | 112,696 | 112,003 | 109,158 | |
Age–area-adjusted HR (95 % CI) | 1.00 | 1.00 (0.92–1.09) | 0.99 (0.91–1.08) | 0.98 (0.89–1.06) | 0.56 |
Multivariate HR (95 % CI) | 1.00 | 1.01 (0.92–1.11) | 1.04 (0.94–1.14) | 1.03 (0.94–1.13) | 0.50 |
Women | |||||
Median intake (μg/day) | 93.7 | 132.2 | 171.5 | 25.3 | |
Number of cases | 635 | 646 | 715 | 683 | |
Person-years of follow-up | 133,894 | 135,104 | 134,924 | 132,963 | |
Age–area-adjusted HR (95 % CI) | 1.00 | 0.99 (0.89–1.10) | 1.05 (0.95–1.18) | 0.98 (0.88–1.10) | 0.96 |
Multivariate HR (95 % CI) | 1.00 | 0.99 (0.88–1.12) | 1.07 (0.96–1.21) | 0.98 (0.87–1.10) | 0.94 |
Inorganic arsenic | |||||
Men | |||||
Median intake (μg/day) | 36.5 | 51.4 | 64.7 | 102.2 | |
Number of cases | 1,084 | 1,072 | 1,042 | 1,125 | |
Person-years of follow-up | 111,399 | 112,541 | 112,403 | 110,017 | |
Age–area-adjusted HR (95 % CI) | 1.00 | 0.96 (0.88–1.05) | 0.91 (0.83–0.99) | 0.94 (0.86–1.02) | 0.09 |
Multivariate HR (95 % CI) | 1.00 | 0.98 (0.89–1.07) | 0.95 (0.87–1.05) | 1.00 (0.91–1.10) | 0.92 |
Women | |||||
Median intake (μg/day) | 37.1 | 51.2 | 64.1 | 107.6 | |
Number of cases | 634 | 649 | 722 | 674 | |
Person-years of follow-up | 134,833 | 134,486 | 134,491 | 133,075 | |
Age–area-adjusted HR (95 % CI) | 1.00 | 1.02 (0.91–1.14) | 1.10 (0.99–1.23) | 1.02 (0.91–1.14) | 0.51 |
Multivariate HR (95 % CI) | 1.00 | 1.00 (0.89–1.12) | 1.08 (0.96–1.22) | 0.99 (0.87–1.11) | 0.85 |
Multivariate HRs were adjusted for age, area, body mass index, smoking status, frequency of alcohol intake, and leisure time physical activity. They were further adjusted for menopausal status and use of exogenous female hormones in women